Femasys Inc. Common Stock FEMY · Stock Open Femasys Inc. Common Stock in new tab
Femasys Inc. Common Stock Analysis (FEMY)
Is Femasys Inc. Common Stock a good investment? Femasys Inc. Common Stock (FEMY) is currently trading at 2.53 USD. Market analysts have a consensus price target of 14.33 USD. This suggests a potential upside from current levels.
Earnings Schedule: Femasys Inc. Common Stock is expected to release its next earnings report on Nov. 17, 2026. The market consensus estimate for Forward EPS is -2.13.
Investor FAQ
Does Femasys Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Femasys Inc. Common Stock?
Femasys Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 17, 2026. The company currently has a trailing EPS of -2.72.
Company Profile
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
| Split Date | Split Ratio to 1 |
|---|---|
| June 8, 2026 | 1:20 |
Community Discussion